Avita Medical Stock Widgets and Gadgets
RCEL Stock | USD 12.82 0.03 0.23% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RCEL Avita Medical
- Latest AVITA Medicals SWOT analysis regenerative medicine firms stock faces growth hurdles
- RCEL 12.82 -0.03
- Low 12.63
- High 13.04
- Alpha 0.34
- Beta 1.78
- Return On Equity -1.52
- Return On Asset -0.45
- Profit Margin (0.95) %
- Operating Margin (0.71) %
- Current Valuation 338.12 M
- Shares Outstanding 26.22 M
- Shares Owned By Insiders 0.90 %
- Shares Owned By Institutions 23.49 %
- Number Of Shares Shorted 1.02 M
- Price To Book 27.55 X
- Price To Sales 5.61 X
- Revenue 50.14 M
- Gross Profit 28.38 M
- EBITDA (57.92 M)
- Net Income (35.38 M)
- Cash And Equivalents 84.17 M
- Cash Per Share 0.67 X
- Total Debt 62.58 M
- Debt To Equity 0.01 %
- Current Ratio 9.64 X
- Book Value Per Share 0.47 X
- Cash Flow From Operations (38.01 M)
- Short Ratio 11.07 X
- Earnings Per Share (2.23) X
- Price To Earnings To Growth (0.04) X
- Target Price 25.89
- Number Of Employees 207
- Beta 1.54
- Market Capitalization 336.9 M
- Total Asset 111.64 M
- Retained Earnings (297.97 M)
- Working Capital 90.81 M
- Net Asset 111.64 M
- Accumulation Distribution 0.0314
- Daily Balance Of Power (0.07)
- Rate Of Daily Change 1.0
- Day Median Price 12.84
- Day Typical Price 12.83
- Market Facilitation Index 0.41
- Price Action Indicator (0.03)
- Period Momentum Indicator (0.03)
- Relative Strength Index 70.14
Market Snapshot Widget Example
DAX Index Germany | 19,626 1.03 | |
Taiwan Weighted Taiwan | 22,262 0.16 | |
PSI 20 Stock Portugal | 6,418 0.2 | |
CROBEX Croatia | 3,162 0.09 | |
Budapest SE Hungary | 77,936 0.56 | |
IDX 30 Jakarta Indonesia | 438.73 2.01 | |
ISEQ 20 Price Ireland | 1,611 1.06 | |
NYSE Comp USA | 20,272 0.31 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,080 2.35 | |
IPC MEXICO Mexico | 49,710 0.21 | |
KL Technology Malaysia | 58.48 0.43 | |
IBEX 35 Index Spain | 11,641 0.26 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,539 0.30 | |
SPASX Dividend Opportunities Australia | 1,697 0.03 | |
HNX 30 Vietnam | 479.79 0.88 | |
Bucharest BET-NG Romania | 1,193 1.32 | |
AMS Small Cap Netherlands | 1,227 1.00 | |
Oslo Exchange Mutual Norway | 1,410 0.22 | |
BEL Small Belgium | 8,012 0.4 | |
Basic Materials Brazil | 5,874 1.78 | |
Swiss Leader Price Switzerland | 1,938 0.35 | |
Fondo Mutuo ETF Chile | 1,367 0.39 | |
Athens General Comp Greece | 1,393 0.74 | |
Stock Exchange Of Thailand | 1,428 0.03 | |
PX Prague Stock Czech Repub | 1,688 0.07 | |
THE PHILIPPINE STOCK Philippines | 6,614 0.37 | |
WIG 30 Poland | 2,809 0.30 | |
BIST Electricity Turkey | 490.89 0.35 |
Investing Ideas
In addition to having Avita Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Avita Medical
Compare Avita Medical To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share 2.335 | Quarterly Revenue Growth 0.432 | Return On Assets (0.45) | Return On Equity (1.52) |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.